BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 31665050)

  • 1. Connecting the dots between different networks: miRNAs associated with bladder cancer risk and progression.
    Braicu C; Buiga R; Cojocneanu R; Buse M; Raduly L; Pop LA; Chira S; Budisan L; Jurj A; Ciocan C; Magdo L; Irimie A; Dobrota F; Petrut B; Berindan-Neagoe I
    J Exp Clin Cancer Res; 2019 Oct; 38(1):433. PubMed ID: 31665050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of key miRNAs and target genes in bladder cancer using miRNA profiling and bioinformatic tools.
    Canturk KM; Ozdemir M; Can C; Öner S; Emre R; Aslan H; Cilingir O; Ciftci E; Celayir FM; Aldemir O; Özen M; Artan S
    Mol Biol Rep; 2014 Dec; 41(12):8127-35. PubMed ID: 25189652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling of microRNAs associated with UCA1 in bladder cancer cells.
    Xie X; Pan J; Wei L; Wu S; Hou H; Li X; Chen W
    Int J Oncol; 2016 Apr; 48(4):1617-27. PubMed ID: 26820254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating miRNAs Act as Diagnostic Biomarkers for Bladder Cancer in Urine.
    Lin JT; Tsai KW
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA expression signatures of bladder cancer revealed by deep sequencing.
    Han Y; Chen J; Zhao X; Liang C; Wang Y; Sun L; Jiang Z; Zhang Z; Yang R; Chen J; Li Z; Tang A; Li X; Ye J; Guan Z; Gui Y; Cai Z
    PLoS One; 2011 Mar; 6(3):e18286. PubMed ID: 21464941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of miRNAs involved in angiogenesis, tumor cell proliferation, tumor suppressor inhibition, epithelial-mesenchymal transition and activation of metastasis in bladder cancer.
    Zaravinos A; Radojicic J; Lambrou GI; Volanis D; Delakas D; Stathopoulos EN; Spandidos DA
    J Urol; 2012 Aug; 188(2):615-23. PubMed ID: 22704449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-30a-5p Inhibits Epithelial-to-Mesenchymal Transition and Upregulates Expression of Tight Junction Protein Claudin-5 in Human Upper Tract Urothelial Carcinoma Cells.
    Chung YH; Li SC; Kao YH; Luo HL; Cheng YT; Lin PR; Tai MH; Chiang PH
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28829370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster.
    Itesako T; Seki N; Yoshino H; Chiyomaru T; Yamasaki T; Hidaka H; Yonezawa T; Nohata N; Kinoshita T; Nakagawa M; Enokida H
    PLoS One; 2014; 9(2):e84311. PubMed ID: 24520312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.
    Li Z; Peng Z; Gu S; Zheng J; Feng D; Qin Q; He J
    Anticancer Res; 2017 Aug; 37(8):4455-4468. PubMed ID: 28739740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual strands of the miR-223 duplex (miR-223-5p and miR-223-3p) inhibit cancer cell aggressiveness: targeted genes are involved in bladder cancer pathogenesis.
    Sugawara S; Yamada Y; Arai T; Okato A; Idichi T; Kato M; Koshizuka K; Ichikawa T; Seki N
    J Hum Genet; 2018 May; 63(5):657-668. PubMed ID: 29540855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational identification of microRNAs associated to both epithelial to mesenchymal transition and NGAL/MMP-9 pathways in bladder cancer.
    Falzone L; Candido S; Salemi R; Basile MS; Scalisi A; McCubrey JA; Torino F; Signorelli SS; Montella M; Libra M
    Oncotarget; 2016 Nov; 7(45):72758-72766. PubMed ID: 27602581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of microRNAs in bladder cancer.
    Enokida H; Yoshino H; Matsushita R; Nakagawa M
    Investig Clin Urol; 2016 Jun; 57 Suppl 1(Suppl 1):S60-76. PubMed ID: 27326409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA Dysregulation in Prostate Cancer.
    Schitcu VH; Raduly L; Nutu A; Zanoaga O; Ciocan C; Munteanu VC; Cojocneanu R; Petrut B; Coman I; Braicu C; Berindan-Neagoe I
    Pharmgenomics Pers Med; 2022; 15():177-193. PubMed ID: 35300057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary Exosomal miRNAs as biomarkers of bladder Cancer and experimental verification of mechanism of miR-93-5p in bladder Cancer.
    Lin H; Shi X; Li H; Hui J; Liu R; Chen Z; Lu Y; Tan W
    BMC Cancer; 2021 Dec; 21(1):1293. PubMed ID: 34861847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
    Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
    Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant expression of microRNAs in bladder cancer.
    Yoshino H; Seki N; Itesako T; Chiyomaru T; Nakagawa M; Enokida H
    Nat Rev Urol; 2013 Jul; 10(7):396-404. PubMed ID: 23712207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA CEP128 promotes bladder cancer progression by regulating Mir-145-5p/Myd88 via MAPK signaling pathway.
    Sun M; Zhao W; Chen Z; Li M; Li S; Wu B; Bu R
    Int J Cancer; 2019 Oct; 145(8):2170-2181. PubMed ID: 30939216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mRNA-miRNA bipartite networks reconstruction in different tissues of bladder cancer based on gene co-expression network analysis.
    Abedi Z; MotieGhader H; Hosseini SS; Sheikh Beig Goharrizi MA; Masoudi-Nejad A
    Sci Rep; 2022 Apr; 12(1):5885. PubMed ID: 35393513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miRNA profiling identifies candidate mirnas for bladder cancer diagnosis and clinical outcome.
    Ratert N; Meyer HA; Jung M; Lioudmer P; Mollenkopf HJ; Wagner I; Miller K; Kilic E; Erbersdobler A; Weikert S; Jung K
    J Mol Diagn; 2013 Sep; 15(5):695-705. PubMed ID: 23945108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.